By Ryan Davis ( August 15, 2022, 7:31 PM EDT) -- The generic drug industry urged the U.S. Supreme Court on Friday to undo a Federal Circuit decision upholding a $235 million patent judgment against Teva, saying it will drive up drug prices by putting generics makers using so-called skinny labels at risk of "extraordinary liability."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.